Autopsy report · NCT01458561

Adjunctive Application of BioFoam Surgical Matrix in Liver Surgery

“Sponsor terminated due to signif. difficulty with pilot investigation enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months after it had already started.
• Ran for about 1 year 11 months before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 2 years 8 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

CryoLife, Inc.

Sponsor type

Industry

Conditions

Intraoperative Bleeding

Interventions

BioFoam Surgical Matrix; Gelfoam Plus

Participants

1

Sites

2

Countries

United States

Trials that died the same way

• Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria
  “Sponsor terminated study” (76% match in meaning)
• Visual Function Tests in Age-related Macular Degeneration
  “Study terminated by Sponsor” (74% match in meaning)
• Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients
  “Study terminated by the Sponsor” (73% match in meaning)
• Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients
  “study terminated early due to change in Sponsorship” (73% match in meaning)
• A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS)
  “Study was terminated based on Sponsor decision” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.